Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions
The Journal of Allergy and Clinical Immunology: In Practice · 2023-06 · 11 (6) · 1688-1697
DOI: 10.1016/j.jaip.2023.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-06. Verfasst von Jagadeesh Bayry und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, Franc…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Fonds de dotation CSL Behring pour la recherche, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Intravenous immunoglobulin (IVIG) is the mainstay of therapy for humoral immune deficiencies and numerous inflammatory disorders. Although the use of IVIG may be supplanted by several targeted therapies to cytokines, the ability of polyclonal normal IgG to act as an effector molecule as well as a regulatory molecule is a clear example of the polyfunctionality of IVIG. This article will address the mechanism of action of IVIG in a number of important conditions that are otherwise resistant to treatment. In this commentary, we will highlight mechanistic studies that shed light on the action of IVIG. This will be approached by identifying effects that are both common and disease-specific, targeting actions that have been demonstrated on cells and processes that represent both innate and adaptive immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France; Department of Biological Sciences and Engineering, Indian Institute…
- Research Institute of McGill University Health Centre, Translational Program in Respiratory Diseases and Department of Pediatrics, McGill University Faculty of Medicine, Montreal, Quebec, Canada.
- Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.
- Research Institute of McGill University Health Centre, Translational Program in Respiratory Diseases and Department of Pediatrics, McGill University Faculty of Medicine, Montreal, Quebec, Canada. Electronic address: Bru…
Förderung
- Fonds de dotation CSL Behring pour la recherche
- Canadian Institutes of Health Research
Zitieren
APA
Bayry, J., Ahmed, E. A., Toscano-Rivero, D., Vonniessen, N., Genest, G., Cohen, C. G., Dembele, M., Kaveri, S. V., & Mazer, B. D. (2023). Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions. The Journal of Allergy and Clinical Immunology: In Practice, 11(6), 1688-1697. https://doi.org/10.1016/j.jaip.2023.04.002
Vancouver
Bayry J, Ahmed EA, Toscano-Rivero D, Vonniessen N, Genest G, Cohen CG, et al. Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(6):1688-1697. doi:10.1016/j.jaip.2023.04.002
BibTeX
@article{Bayry2023,
author = {Bayry, Jagadeesh and Ahmed, Eisha A and Toscano-Rivero, Diana and Vonniessen, Nicholas and Genest, Genevieve and Cohen, Casey G and Dembele, Marieme and Kaveri, Srini V and Mazer, Bruce D},
title = {Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
volume = {11},
number = {6},
pages = {1688--1697},
doi = {10.1016/j.jaip.2023.04.002}
}
EUVIMED